DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors.
Jin-Sung ChungVijay RamaniMasato KobayashiFarjana FattahVinita PopatSong ZhangPonciano D CruzDavid E GerberKiyoshi AriizumiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
sDC-HIL in the blood and probably DC-HIL receptor expressed by MDSC play an important role in regulating response to ICI in advanced NSCLC.